A high-throughput assay for modulators of NNT activity in permeabilized yeast cells.
Nicotinamide nucleotide transhydrogenase (NNT) mutant mice show glucose intolerance with impaired insulin secretion during glucose tolerance tests. Uncoupling of the β cell mitochondrial metabolism due to such mutations makes NNT a novel target for therapeutics in the treatment of pathologies such a...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|
| _version_ | 1797103480283856896 |
|---|---|
| author | Meadows, N Saxty, B Albury, MS Kettleborough, C Ashcroft, F Moore, A Cox, R |
| author_facet | Meadows, N Saxty, B Albury, MS Kettleborough, C Ashcroft, F Moore, A Cox, R |
| author_sort | Meadows, N |
| collection | OXFORD |
| description | Nicotinamide nucleotide transhydrogenase (NNT) mutant mice show glucose intolerance with impaired insulin secretion during glucose tolerance tests. Uncoupling of the β cell mitochondrial metabolism due to such mutations makes NNT a novel target for therapeutics in the treatment of pathologies such as type 2 diabetes. The authors propose that increasing NNT activity would help reduce deleterious buildup of reactive oxygen species in the inner mitochondrial matrix. They have expressed human Nnt cDNA for the first time in Saccharomyces cerevisiae, and transhydrogenase activity in mitochondria isolated from these cells is six times greater than is seen in wild-type mitochondria. The same mitochondria have partially uncoupled respiration, and the cells have slower growth rates compared to cells that do not express NNT. The authors have used NNT's role as a redox-driven proton pump to develop a robust fluorimetric assay in permeabilized yeast. Screening in parallel a library of known pharmacologically active compounds (National Institute of Neurological Disorders and Stroke collection) against NNT ± cells, they demonstrate a robust and reproducible assay suitable for expansion into larger and more diverse compound sets. The identification of NNT activators may help in the elucidation of the role of NNT in mammalian cells and assessing its potential as a therapeutic target for insulin secretion disorders. |
| first_indexed | 2024-03-07T06:20:44Z |
| format | Journal article |
| id | oxford-uuid:f2a1a2f2-7a70-4240-bbfe-ba9566a7e069 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:20:44Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:f2a1a2f2-7a70-4240-bbfe-ba9566a7e0692022-03-27T12:05:22ZA high-throughput assay for modulators of NNT activity in permeabilized yeast cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f2a1a2f2-7a70-4240-bbfe-ba9566a7e069EnglishSymplectic Elements at Oxford2011Meadows, NSaxty, BAlbury, MSKettleborough, CAshcroft, FMoore, ACox, RNicotinamide nucleotide transhydrogenase (NNT) mutant mice show glucose intolerance with impaired insulin secretion during glucose tolerance tests. Uncoupling of the β cell mitochondrial metabolism due to such mutations makes NNT a novel target for therapeutics in the treatment of pathologies such as type 2 diabetes. The authors propose that increasing NNT activity would help reduce deleterious buildup of reactive oxygen species in the inner mitochondrial matrix. They have expressed human Nnt cDNA for the first time in Saccharomyces cerevisiae, and transhydrogenase activity in mitochondria isolated from these cells is six times greater than is seen in wild-type mitochondria. The same mitochondria have partially uncoupled respiration, and the cells have slower growth rates compared to cells that do not express NNT. The authors have used NNT's role as a redox-driven proton pump to develop a robust fluorimetric assay in permeabilized yeast. Screening in parallel a library of known pharmacologically active compounds (National Institute of Neurological Disorders and Stroke collection) against NNT ± cells, they demonstrate a robust and reproducible assay suitable for expansion into larger and more diverse compound sets. The identification of NNT activators may help in the elucidation of the role of NNT in mammalian cells and assessing its potential as a therapeutic target for insulin secretion disorders. |
| spellingShingle | Meadows, N Saxty, B Albury, MS Kettleborough, C Ashcroft, F Moore, A Cox, R A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. |
| title | A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. |
| title_full | A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. |
| title_fullStr | A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. |
| title_full_unstemmed | A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. |
| title_short | A high-throughput assay for modulators of NNT activity in permeabilized yeast cells. |
| title_sort | high throughput assay for modulators of nnt activity in permeabilized yeast cells |
| work_keys_str_mv | AT meadowsn ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT saxtyb ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT alburyms ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT kettleboroughc ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT ashcroftf ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT moorea ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT coxr ahighthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT meadowsn highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT saxtyb highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT alburyms highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT kettleboroughc highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT ashcroftf highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT moorea highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells AT coxr highthroughputassayformodulatorsofnntactivityinpermeabilizedyeastcells |